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Arrhythmogenic cardiomyopathy (ACM), formerly known
as arrhythmogenic right ventricular dysplasia, is a primary
myocardial disorder characterized by ventricular arrhythmias
and sudden cardiac death (SCD).1 Myocardial desmosomes
are cell–cell junctions that reside within the intercalated
disc. They consist of members of the cadherin family (desmo-
collin-2, desmoglein-2), which span the membrane mechan-
ically coupling adjacent cells, and members of the plakin and
armadillo families: plakoglobin (PKG), plakophilin-2
(PKP2), and desmoplakin (DSP1), which connect the cad-
herin complexes to the intermediate cytoskeleton ﬁlaments.
A reduction in the PKG immunoreactive signal has been
shown at intercalated discs of cardiomyocytes in ACM
regardless of the underlying pathogenic mutation.1,2 Herein
we report 2 unusual cases of ACM with digenic
heterozygosity showing normal immunoreactive PKG
distribution but reduced DSP1 signal at myocardial cell–
cell junctions without known pathogenicity in the DSP gene.Case report
Two unrelated male patients, aged 28 and 31 years old at time
of ﬁrst symptoms, complained of syncope during strenuous
exercise. They had no known comorbidities and no family
history of SCD. Both practiced high-intensity sports.
Figure 1A shows the resting electrocardiograms of both
cases. Despite some minor anomalies, there was no sign sug-
gestive of ACM. The echocardiogram, coronary angiogram,KEYWORDS Arrhythmogenic cardiomyopathy; Desmosomal disease;
Epicardial ablation; Immunoﬂuorescence; Ventricular tachycardia
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nance imaging (CMR) in patient 1 showed a limited (1-
segment) nontransmural area of late gadolinium enhance-
ment (LGE) in the inferolateral left ventricle (LV) wall and
a local hypokinesia of the right ventricular outﬂow tract
(RVOT) on the cine short axis as well as a discrete right
ventricle (RV) dilation considered borderline in a sportive
patient (Supplemental Figure 1A–C). The CMR in patient
2 was normal (Supplemental Figure 1E–F). A metabolic
FDG18 PET scan showed no focal activity. Signal-averaged
electrocardiogram as well as higher precordial or speciﬁc
Fontaine leads were not obtained at time of referral, which
might have revealed epsilon waves suggestive of a subclini-
cal ACM.
An electrophysiological study in patient 1 and a treadmill
test in patient 2 revealed a monomorphic ventricular tachy-
cardia (mVT) originating from the RVOT, as suggested by
the inferior axis and the late transition occurring in lead V4
(Figure 1B). An ablation was attempted in both cases using
a 3-dimensional electroanatomic system (Carto 3, Biosense
Webster, Inc, Diamond Bar, CA). A limited area of reduced
bipolar voltage suggestive of a scar was observed on the
anterolateral RVOT (Figure 2, endocardial mapping sec-
tions). Importantly, these reduced potentials preceded the
ventricular tachycardia (VT) by 30 ms and were successfully
ablated with noninducibility at the end of the procedures.
The initial diagnosis was idiopathic RVOT VT, and both
patients were initiated on beta-blockers. After 2 and 9
months, respectively, both patients were referred again to
our center for syncope during exercise. Symptomatic VT
with a different morphology than the index arrhythmia in
case 1, and VT of different cycle lengths in case 2
(Supplemental Figure 2), prompted a second endocardial
ablation, deemed successful in case 1 and unsuccessful in
case 2 because of inducibility at the end of the procedure.
Amiodarone was then introduced. In view of early recurrenceen access article
.0/).
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KEY TEACHING POINTS
 Some arrhythmogenic right ventricular dysplasia/
cardiomyopathy might present as sustained
ventricular tachycardia (VT) without overt
structural heart disease.
 Recurrent VTs suggest an epicardial disease that
can be further suspected by biopsies.
 Normal plakoglobin but reduced desmoplakin
immunoﬂuorescence staining signals on cardiac
biopsies may be indicative of arrhythmogenic
cardiomyopathy.
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index arrhythmia, there was increasing concern of an incip-
ient ACM.3 An implantable cardioverter-deﬁbrillator (ICD)
was implanted and an epicardial ablation was programmed.
Figure 2A and B shows an extended area overlying most of
the RV epicardium (900 points) made of low-voltage electro-
grams depicted as a shade of colors from red (dense scar,
,0.5 mV) to blue (,1.5 mV), and late abnormal ventricular
activations (LAVA) and fragmented potentials (blue and
pink dots, respectively). Ablation primarily targeted the
“early” LAVA (Figure 2A), then whether mid and late
LAVAs were still present was checked immediately, with
noninducibility at the end of the procedure. Amiodarone
was discontinued immediately after the epicardial VT abla-
tion and beta-blocker treatment resumed. Septal RV biopsies,
taken at the time of the second endocardial ablation, revealed
no morphologic abnormality. Immunoﬂuorescence staining
(IF) of desmosomal proteins was performed on the biopsies
and compared to a control sample. The following proteins
were tested: PKG, PKP2, DSP1, desmin (DES), connexin
43, and N-cadherin. IF revealed in both cases a severely
reduced signal forDSP1 at cell–cell junctions but normal dis-
tribution of other proteins (Figure 3). Interestingly, negative
T waves occurred in leads V2 and V3 over a 3-year follow-up
period before any epicardial procedure (Figure 1C).
Repeat imaging studies, performed at 10 and 12 months
after symptom onset, respectively (before ICD implant in pa-
tient 1 and after ICD implant in patient 2), provided a major
ACM criterion for patient 1 (segmental akinesia to dyskinesia
with RV dilation, no change in the LV at CMR) and a minor
criterion in patient 2 (RV free wall akinesia with normal func-
tion at echocardiogram). In the presence of 3 major criteria in
patient 1 (imaging, sustained mVT, and repolarization abnor-
malities) and 1 major (repolarization abnormalities) 1 2
minor criteria in patient 2 (sustained mVT and imaging),
the diagnosis of ACM was established.4 Patients were
advised to refrain from intense physical activity according
to current guidelines.5 Over a 3- and 5-year follow-up no
VT recurrence occurred after epicardial ablation.Genetic analysis was performed in both cases (details in
Supplemental Data). In patient 1, mutational analysis re-
vealed 3 heterozygous variants: 1 likely pathogenic alteration
in the DES gene: NM_001927.3:c.638C.T (p.Ala213Val)
and 1 likely pathogenic variant in the CTNNA3 gene:
NM_001127384.1:c.1603C.T (p.Arg535Cys); and an addi-
tional variant of unknown signiﬁcance identiﬁed in theDSG2
gene: NM_001943.3:c.877A.G (p.Ile293Val).
In patient 2, mutational analysis also revealed 3 heterozy-
gous variants: a pathogenic mutation in the PKP2 gene:
NM_004572.3:c.2197_2202delCACACCinsG (p.His733A-
lafsTer8); and 2 variants of unknown signiﬁcance in the
DSG2 gene: NM_001943.3:c.2759T.G (p.Val920Gly) and
DSP gene: NM_004415.2:c.6208G.A (p.Asp2070Asn).Discussion
The diagnosis of ACM remains challenging owing to the age-
related progression, vast phenotypic variation, and reduced
genetic penetrance.1,6 We report here 2 young patients
presenting with arrhythmias displaying the typical
morphology of RVOT VT. VT occurred years before any
structural disease was declared. Importantly, none of the
initial VTs displayed the typical features of a right
epicardial origin, such as Q waves in II, III, aVF or Q
waves in I.7 Cardiac sarcoidosis was reasonably excluded
by multimodality imaging.1,8
Importantly, IF of myocardial biopsies showed reduced
DSP1 signal at junctional sites. Reduced DSP1 signal at
intercalated discs has been recently reported in the majority
of cases of dilated cardiomyopathy (DCM).9 In our cases,
however, the normal RV and LV ejection fraction at the
time of the biopsies and the lack of a clear DCM phenotype
after several years of follow-up reasonably exclude DCM as
the underlying causative disease. Interestingly, RV imaging
abnormalities and T-wave inversion occurred more than 2
years after VT onset, conﬁrming that some ACM might pre-
sent with arrhythmic events in the absence of any structural
heart disease.2,6
Although not yet part of the current guidelines for the
diagnosis of ACM,4 IF staining appears to be a promising
tool giving insights into tissue characterization up to the
desmosomal subunits.9 Intercalated disc anomalies occur in
many diseases, including severe heart failure, but they are
always accompanied by histologic abnormalities.6 The
occurrence of an abnormal intercalated disc IF signal in his-
tologically unaffected regions of the myocardium appears
typical of ACM.1,2,6 IF of endomyocardial biopsies can
reliably identify ACM even in the absence of genetic
mutations.9,10 The main intercalated disc culprits included
PKG9 and connexin 43.10 While both were highly sensitive
in the setting of ACM,9,10 only reduced PKG signal was
highly speciﬁc for the diagnosis of ACM.9 Our patients
showed a selective reduction of desmosomal DSP1 expres-
sion, while the distribution of PKG appeared normal. IF bears
some limitations that were addressed here to limit the risk of
false-negatives. All biopsies were ﬁxed within minutes after
Figure 1 A: Baseline 12-lead electrocardiogram showing normal sinus rhythm with 1.5 mm J-point elevation in V3–V5 in patient 1 and normal sinus rhythm
with late R-wave progression in precordial leads and incomplete right bundle branch block in V1 not fulﬁlling the criterion for an epsilonwave in patient 2.B:Left:
Sustained monomorphic ventricular tachycardia (heart rate 214 beats/min) induced during an electrophysiological study in patient 1. Right: Nonsustained
ventricular tachycardia (heart rate 230 beats/min) occurring during an exercise stress test in patient 2. C: Progressive occurrence of negative T waves up to
V3 over a 3-year follow-up.
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Figure 2 A: Left: Endocardial bipolar map based on a 3-dimensional electroanatomic system in patient 1. Note the presence of a limited area of low-voltage
potentials in the anterolateral right ventricular outﬂow tract (RVOT). Right: Epicardial bipolar map showing an extended area of low-voltage potentials overlying
most of the right ventricular (RV) epicardium. Examples of early (a), mid (b), and late (c) late abnormal ventricular activations are shown on the right-hand side.B:
Left: Endocardial bipolar map in patient 2. A limited number of fragmented potentials in the anterolateral RVOT are shown as pink dots. Right: Epicardial bipolar
map showing an extended area of low-voltage potentials overlying most of the RV epicardium.
60 Heart Rhythm Case Reports, Vol 5, No 2, February 2019harvesting and compared to a control to ensure that the
reduced DSP IF signal stemmed from the disease and not
from the technique. DSP1 is the dominant isoform in cardiac
tissue.6 Traditionally, loss of DSP1 was described by Alcalaiand colleagues11 and Uzumcu and colleagues12 as part of a
cardiocutaneus syndrome. In 2005, Norman and colleagues13
identiﬁed an ACM mutation in DSP1 with subsequent pro-
tein truncation,2,6 which mainly involved the LV. To our
Figure 3 Immunoﬂuorescence staining of intercalated disc proteins in a control subject and in patients 1 and 2.
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DSP1 signal that mainly affects the RV without associated
skin and hair disease.
The discovery of causative mutations in desmosomal
genes has shed light into ACM pathogenesis.2 Nevertheless,
much less is known about how the mutant proteins actually
cause the disease. A mutation in a single desmosomal pro-
tein can affect the localization of other proteins not geneti-
cally mutated.2 They appear to play a role in cell death
through abnormal cell–cell adhesion and as signaling pro-
teins. Interestingly, redistribution of PKG and DSP1 are
involved in abnormal transcriptional activity and protein
trafﬁcking and in increased expression of ﬁbrogenic and
adipogenic genes.2 Our ﬁrst case exhibited a mutation in
the DES and catenin genes and the second case a mutation
in the PKP2 gene, all encoding for proteins tightly con-
nected to DSP1. Hence, it is possible that these abnormal
proteins, although correctly expressed at the intercalated
disc, might have limited the trafﬁcking of DSP1. Another
ﬁnding is the presence of multiple heterozygous gene vari-
ants, which carry a worse prognosis in terms of survival and
disease progression.1,14
Antiarrhythmic drugs are prescribed in ACM to reduce the
arrhythmic burden, but they have no impact on preventing
SCD.5 Catheter ablation has become an option for refractory
VT.15 Substrate-based ablation has improved the procedural
outcome by targeting multiple epicardial circuits typically
seen in ACM.5,15 Further studies are warranted to
determine whether desmosome imaging techniques could
predict the presence of an epicardial substrate suitable for
ablation in suspected cases of ACM.Conclusion
We report 2 ACM cases with RVOT VTs displaying an iso-
lated reducedDSP1 signal at intercalated discs from histolog-
ically normal myocardial tissue. Although the RVmight look
unremarkable at histologic examination, the ability to sustain
recurrent VT suggests a complex epicardial substrate that can
be further suspected by IF studies of endomyocardial bi-
opsies.
Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at https://doi.org/10.1016/j.hrcr.2018.
06.013.
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